Search research articles
Contact Us
Filters
Showing results (871-880 of 1,066) with videos related to
Page
of 107
Sort By:
Cancer Discovery
|
July 17, 2016
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
The American Journal of Pathology
|
November 14, 2009
Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts
Peter Fickert, Andrea Fuchsbichler, Tarek Moustafa, et al.
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Targeted Oncology
|
February 24, 2023
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
Maureen Caligiuri, Grace L Williams, Jennifer Castro, et al.
JCI Insight
|
February 4, 2025
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors
Miguel A Villalona-Calero, Lei Tian, Xiaochen Li, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 19, 2025
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
Thomas Scattolin, Enrico Cavarzerani, Dario Alessi, et al.
Blood
|
March 19, 2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy
Susan P Whitman, Shujun Liu, Tamara Vukosavljevic, et al.
Blood
|
December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li, Li Gao, Xufeng Luo, et al.
Nanophotonics (Berlin, Germany)
|
June 11, 2025
Disordered plasmonic system with dense copper nano-island morphology
Tlek Tapani, Vincenzo Caligiuri, Yanqiu Zou, et al.
RSC Advances
|
May 2, 2025
Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexes
Tommaso Lorenzon, Maria Vescovo, Michele Maiullari, et al.
Page
of 107
Search research articles
Search
Showing results (871-880 of 1,066) with videos related to
Sort By:
Page
of 107
Cancer Discovery
|
July 17, 2016
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
The American Journal of Pathology
|
November 14, 2009
Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts
Peter Fickert, Andrea Fuchsbichler, Tarek Moustafa, et al.
Cancer Cell
|
November 16, 2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani, Ramasamy Santhanam, Rossana Trotta, et al.
Targeted Oncology
|
February 24, 2023
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
Maureen Caligiuri, Grace L Williams, Jennifer Castro, et al.
JCI Insight
|
February 4, 2025
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors
Miguel A Villalona-Calero, Lei Tian, Xiaochen Li, et al.
Dalton Transactions (Cambridge, England : 2003)
|
February 19, 2025
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
Thomas Scattolin, Enrico Cavarzerani, Dario Alessi, et al.
Blood
|
March 19, 2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy
Susan P Whitman, Shujun Liu, Tamara Vukosavljevic, et al.
Blood
|
December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li, Li Gao, Xufeng Luo, et al.
Nanophotonics (Berlin, Germany)
|
June 11, 2025
Disordered plasmonic system with dense copper nano-island morphology
Tlek Tapani, Vincenzo Caligiuri, Yanqiu Zou, et al.
RSC Advances
|
May 2, 2025
Influence of the charge of 1,3,5-triaza-7-phosphaadamantane-based ligands on the anticancer activity of organopalladium complexes
Tommaso Lorenzon, Maria Vescovo, Michele Maiullari, et al.
Page
of 107